Page 43 - Children Program News Today

The shortage of nirsevimab has public health officers frustrated, especially as the nation heads into the winter.

The Centers for Disease Control and Prevention said it was releasing 77,000 additional doses of a respiratory syncytial virus (RSV) drug from Sanofi and AstraZeneca to help improve its availability. The additional doses of Beyfortus will be distributed immediately to physicians and hospitals through the Vaccines for Children Program, which covers the cost of the…

(The Center Square) – Forty-five U.S. House Republicans voted with Democrats against an amendment to remove an agency head at the center of ongoing allegations of child abuse and neglect.

CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos.

The CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.

'We will miss your sparking blue eyes, your laughter, your comforting, loving presence.'

Forty-five U.S. House Republicans voted with Democrats against an amendment to remove an agency head at the center of ongoing allegations of child abuse and neglect. 

Amid an ongoing shortage of nirsevimab, an RSV immunization for young children, the CDC has announced that more than 77,000 additional doses will be distributed “immediately.”

CDC and FDA will continue to be in close contact with manufacturers to ensure the availability of additional doses through end of this year and for early 2024 to meet the demand...

The U.S.